Cliff Asness’s OnKure Therapeutics OKUR Stock Holding History

Cliff Asness’s Portfolio OKUR Stock Details OKUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,040	Closed	-$15.7K	–	2887
2024 Q2	$15.7K	Buy	+1,040	New	+$17.6K	﹤0.01%	2578

Other funds holding OKUR

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cliff Asness's OKUR Position: Q3 2024 in Review

Cliff Asness sold out of OnKure Therapeutics (OKUR) in Q3 2024, closing a stake of 1,040 shares — an estimated $15.7K sold.

Cliff Asness first reported a position in OKUR in Q2 2024 and held it in 1 quarter. The position peaked at $15.7K in Q2 2024. 51 funds tracked by Wall St. Rank hold OKUR as of Q3 2024.

Cliff Asness reported no remaining OnKure Therapeutics position as of Q3 2024 after selling out during the quarter.
Cliff Asness sold 1,040 OnKure Therapeutics shares in Q3 2024, an estimated $15.7K.
Cliff Asness first reported a position in OnKure Therapeutics in Q2 2024 and held it in 1 quarter.
Cliff Asness's OnKure Therapeutics position peaked at $15.7K in Q2 2024.
51 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q3 2024.

Based on AQR Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.